1| SENATE FLOOR VERSION | | February 16, 2026 | 2| AS AMENDED | | | 3|SENATE BILL NO. 1591 By: Rosino of the Senate | | | 4| and | | | 5| Newton of the House | | | 6| | | | 7| | | | 8| An Act relating to medical marijuana; amending 63 | | O.S. 2021, Sections 423, as last amended by Section | 9| 8, Chapter 182, O.S.L. 2024 and 427.18, as last | | amended by Section 1, Chapter 272, O.S.L. 2025 (63 | 10| O.S. Supp. 2025, Sections 423 and 427.18), which | | relate to medical marijuana processing license and | 11| packaging and labeling requirements; limiting certain | | tetrahydrocannabinol (THC) amounts in certain | 12| products and packages; updating statutory language; | | and declaring an emergency. | 13| | | | 14| | | | 15|BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: | | | 16| SECTION 1. AMENDATORY 63 O.S. 2021, Section 423, as last | | | 17|amended by Section 8, Chapter 182, O.S.L. 2024 (63 O.S. Supp. 2025, | | | 18|Section 423), is amended to read as follows: | | | 19| Section 423. A. The Oklahoma Medical Marijuana Authority shall | | | 20|make available on its website in an easy-to-find location an | | | 21|application for a medical marijuana processing license. The | | | 22|Authority shall be authorized to issue two types of medical | | | 23|marijuana processor licenses based on the level of risk posed by the | | | 24|type of processing conducted: | | | arsid14962042 SENATE FLOOR VERSION - SB1591 SFLR Page 1 ___________________________________________________________________________
1| 1. Nonhazardous medical marijuana processor license; and | | | 2| 2. Hazardous medical marijuana processor license. | | | 3|The application fee for a nonhazardous or hazardous medical | | | 4|marijuana processor license shall be paid by the applicant in the | | | 5|amounts provided for in Section 427.14 of this title. A method of | | | 6|payment shall be provided on the website of the Authority. The | | | 7|Authority shall have ninety (90) business days to review the | | | 8|application; approve, reject, or deny the application; and send the | | | 9|approval, rejection, or denial letter stating the reasons for the | | | 10|rejection or denial to the applicant in the same method the | | | 11|application was submitted to the Authority. | | | 12| B. The Authority shall approve all applications which meet the | | | 13|following criteria: | | | 14| 1. The applicant must be twenty-five (25) years of age or | | | 15|older; | | | 16| 2. The applicant, if applying as an individual, must show | | | 17|residency in this state; | | | 18| 3. All applying entities must show that all members, managers, | | | 19|and board members areOklahomaresidents of this state; | | | 20| 4. An applying entity may show ownership of nonstate residents, | | | 21|but that percentage ownership may not exceed twenty-five percent | | | 22|(25%); | | | 23| 5. All applying individuals or entities must be registered to | | | 24|conduct business in this state; and | | | arsid14962042 SENATE FLOOR VERSION - SB1591 SFLR Page 2 ___________________________________________________________________________
1| 6. All applicants must disclose all ownership interests in the | | | 2|processing operation. | | | 3| Applicants with a nonviolent felony conviction in the last two | | | 4|(2) years, any other felony conviction in the last five (5) years, | | | 5|inmates in the custody of the Department of Corrections or any | | | 6|person currently incarcerated shall not qualify for a medical | | | 7|marijuana processing license. | | | 8| C. 1. A licensed processor may take marijuana plants and | | | 9|distill or process these plants into concentrates, edibles, and | | | 10|other forms for consumption. No individual edible medical marijuana | | | 11|product shall include more than ten (10) milligrams of | | | 12|tetrahydrocannabinol (THC) per edible and no more than one hundred | | | 13|(100) milligrams of THC per package. | | | 14| 2. The Executive Director of the Authority shall make available | | | 15|a set of standards which shall be used by licensed processors in the | | | 16|preparation of edible marijuana products. The standards should be | | | 17|in line with current food preparation guidelines. No excessive or | | | 18|punitive rules may be established by the Executive Director. | | | 19| 3. Up to two times a year, the Authority may inspect a | | | 20|processing operation and determine its compliance with the | | | 21|preparation standards. If deficiencies are found, a written report | | | 22|of the deficiency shall be issued to the licensed processor. The | | | 23|licensed processor shall have one (1) month to correct the | | | 24| | | | arsid14962042 SENATE FLOOR VERSION - SB1591 SFLR Page 3 ___________________________________________________________________________
1|deficiency or be subject to a fine of Five Hundred Dollars ($500.00) | | | 2|for each deficiency. | | | 3| 4. A licensed processor may sell marijuana products it creates | | | 4|to a licensed dispensary or any other licensed processor. All sales | | | 5|by a licensed processor shall be considered wholesale sales and | | | 6|shall not be subject to taxation. | | | 7| 5. Under no circumstances may a licensed processor sell | | | 8|marijuana or any marijuana product directly to a licensed medical | | | 9|marijuana patient or licensed caregiver. However, a licensed | | | 10|processor may process cannabis into a concentrated form for a | | | 11|licensed medical marijuana patient for a fee. | | | 12| 6. Licensed processors shall be required to complete a monthly | | | 13|yield and sales report to the Authority. This report shall be due | | | 14|on the fifteenth of each month and shall provide reporting on the | | | 15|previous month. This report shall detail the amount of marijuana | | | 16|and medical marijuana products purchased in pounds, the amount of | | | 17|marijuana cooked or processed in pounds, and the amount of waste in | | | 18|pounds. Additionally, this report shall show total wholesale sales | | | 19|in dollars. The Authority shall have oversight and auditing | | | 20|responsibilities to ensure that all marijuana being processed is | | | 21|accounted for. | | | 22| D. The Authority shall oversee the inspection and compliance of | | | 23|licensed processors producing products with marijuana as an | | | 24| | | | arsid14962042 SENATE FLOOR VERSION - SB1591 SFLR Page 4 ___________________________________________________________________________
1|additive. If it becomes permissible under federal law, marijuana | | | 2|may be moved across state lines. | | | 3| E. Any device used for the processing or consumption of medical | | | 4|marijuana shall be considered legal to be sold, manufactured, | | | 5|distributed, and possessed. No merchant, wholesaler, manufacturer, | | | 6|or individual may be unduly harassed or prosecuted for selling, | | | 7|manufacturing, or possessing marijuana paraphernalia. | | | 8| SECTION 2. AMENDATORY 63 O.S. 2021, Section 427.18, as | | | 9|last amended by Section 1, Chapter 272, O.S.L. 2025 (63 O.S. Supp. | | | 10|2025, Section 427.18), is amended to read as follows: | | | 11| Section 427.18. A. A medical marijuana business shall not | | | 12|sell, transfer, or otherwise distribute medical marijuana or medical | | | 13|marijuana product that has not been packaged and labeled in | | | 14|accordance with this section and rules promulgated by the Executive | | | 15|Director of the Oklahoma Medical Marijuana Authority. | | | 16| B. A medical marijuana dispensary shall return medical | | | 17|marijuana and medical marijuana product that does not meet packaging | | | 18|or labeling requirements in this section or rules promulgated | | | 19|pursuant thereto to the entity who transferred it to the dispensary. | | | 20| The medical marijuana dispensary shall document to whom the item | | | 21|was returned, what was returned, and the date of the return, or | | | 22|dispose of any usable marijuana that does not meet these | | | 23|requirements in accordance with the Oklahoma Medical Marijuana and | | | 24|Patient Protection Act. | | | arsid14962042 SENATE FLOOR VERSION - SB1591 SFLR Page 5 ___________________________________________________________________________
1| C. 1. Medical marijuana packaging shall be packaged to | | | 2|minimize its appeal to children and shall not depict images other | | | 3|than the business name logo of the medical marijuana producer and | | | 4|image of the product. | | | 5| 2. A medical marijuana business shall not place any content on | | | 6|a container in a manner that reasonably appears to target | | | 7|individuals under the age of twenty-one (21) including, but not | | | 8|limited to, cartoon characters or similar images. | | | 9| 3. Labels on a container shall not include any false or | | | 10|misleading statements. | | | 11| 4. No container shall be intentionally or knowingly labeled so | | | 12|as to cause a reasonable patient confusion as to whether the medical | | | 13|marijuana, medical marijuana concentrate, or medical marijuana | | | 14|product is a trademarked product or labeled in a manner that | | | 15|violates any federal trademark law or regulation. The label on the | | | 16|container shall include a warning that states the following: | | | 17| a. "For use by licensed medical marijuana patients | | | 18| only", | | | 19| b. "Keep out of reach of children", | | | 20| c. "It is illegal to drive a motor vehicle while under | | | 21| the influence of marijuana or marijuana products", | | | 22| d. "Women should not use marijuana or marijuana products | | | 23| during pregnancy because of the risk of birth | | | 24| defects", and | | | arsid14962042 SENATE FLOOR VERSION - SB1591 SFLR Page 6 ___________________________________________________________________________
1| e. "This product has been tested for contaminants". | | | 2| 5. The label on the container shall not make any claims | | | 3|regarding health or physical benefits to the patient. | | | 4| 6. The container itself may be clear in order to allow licensed | | | 5|medical marijuana patients and licensed medical marijuana caregivers | | | 6|the ability to view the product inside the container but shall be | | | 7|child-resistant, as defined in Section 427.2 of this title. | | | 8| 7. At the point of sale and transfer of any medical marijuana, | | | 9|medical marijuana concentrate, or medical marijuana products to a | | | 10|licensed medical marijuana patient or licensed medical marijuana | | | 11|caregiver, the dispensary shall place the medical marijuana, medical | | | 12|marijuana concentrate, or medical marijuana products in an exit | | | 13|package, as such term is defined in Section 427.2 of this title. | | | 14| 8. No individual edible medical marijuana product sold shall | | | 15|include more than ten (10) milligrams of tetrahydrocannabinol (THC) | | | 16|per edible and no more than one hundred (100) milligrams of THC per | | | 17|package. | | | 18| D. The Executive Director shall develop minimum standards for | | | 19|packaging and labeling of medical marijuana, medical marijuana | | | 20|concentrate, and medical marijuana products. Such standards shall | | | 21|include, but not be limited to, the required contents of labels to | | | 22|be affixed to all medical marijuana, medical marijuana concentrate, | | | 23|and medical marijuana products prior to transfer to a licensed | | | 24|patient or caregiver, which shall include, at a minimum: | | | arsid14962042 SENATE FLOOR VERSION - SB1591 SFLR Page 7 ___________________________________________________________________________
1| 1. THC and other cannabinoid potency, and terpenoid potency; | | | 2| 2. A statement indicating that the product has been tested for | | | 3|contaminants; | | | 4| 3. One or more product warnings to be determined by the | | | 5|Executive Director; and | | | 6| 4. Any other information the Executive Director deems | | | 7|necessary. | | | 8| SECTION 3. It being immediately necessary for the preservation | | | 9|of the public peace, health or safety, an emergency is hereby | | | 10|declared to exist, by reason whereof this act shall take effect and | | | 11|be in full force from and after its passage and approval. | | | 12|COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES | |February 16, 2026 - DO PASS AS AMENDED | 13| | | | 14| | | | 15| | | | 16| | | | 17| | | | 18| | | | 19| | | | 20| | | | 21| | | | 22| | | | 23| | | | 24| | | | arsid14962042 SENATE FLOOR VERSION - SB1591 SFLR Page 8